Internal Medicine, Cardiovascular Disease · Nashville, TN
NPI
1326086653
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4230 Harding Rd, Suite 330
Nashville, TN, 37205
Phone (615) 269-4545
Groups this clinician bills Medicare through
Medicare paid, 2024
$231K
4,949 services
Medicare patients, 2024
2,231
Average age 75
Drug cost, 2024
$908K
5,715 prescriptions
Company payments, 2025
$79.64
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dante J Graves was code 99214 (office e&m - established), 925 times for 731 patients. In total Dante J Graves billed 4,949 services in 53 codes, and Medicare paid $231K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-10-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 925 | 731 | $77.63 | $72K |
| 93306 Echocardiography (TTE/TEE) | Facility | 717 | 701 | $47.93 | $34K |
| 93010 Electrocardiogram | Facility | 415 | 323 | $5.91 | $2,454 |
| 93018 Electrocardiogram | Facility | 384 | 380 | $9.48 | $3,641 |
| 78452 Myocardial Perfusion Scan | Facility | 334 | 333 | $50.29 | $17K |
| 99204 Office E&M - New | Office | 202 | 202 | $98.75 | $20K |
| 93320 Echocardiography (TTE/TEE) | Facility | 190 | 184 | $12.39 | $2,354 |
| 93000 Electrocardiogram | Office | 184 | 176 | $8.57 | $1,576 |
| 93312 Echocardiography (TTE/TEE) | Facility | 179 | 173 | $74.35 | $13K |
| 93325 Echocardiography (TTE/TEE) | Facility | 166 | 158 | $2.20 | $366 |
| 76376 CT Scan | Facility | 134 | 130 | $6.78 | $908 |
| 99232 Hospital E&M - Subsequent | Facility | 128 | 70 | $55.96 | $7,163 |
| 93016 Electrocardiogram | Facility | 120 | 119 | $14.11 | $1,694 |
| 93458 Percutaneous Transcatheterization | Facility | 80 | 79 | $200.17 | $16K |
| 78431 Myocardial Perfusion Scan | Facility | 76 | 74 | $61.71 | $4,690 |
By year: 2022 $238K for 4,549 services; 2023 $217K for 4,660 services; 2024 $231K for 4,949 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 86 | 15 | $4.23 | $364 |
Medicare prescription drug claims, 2024
In 2024, the drug Dante J Graves prescribed most often to Medicare patients was Atorvastatin Calcium, with 512 prescriptions and refills. In total Dante J Graves wrote 5,715 Medicare prescriptions that cost $908K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 512 | 1,440 | 171 | $5,840 |
| Metoprolol Succinate Generic | 421 | 1,190 | 150 | $6,149 |
| Eliquis Apixaban | 382 | 693 | 91 | $404K |
| Losartan Potassium Generic | 361 | 1,023 | 127 | $4,640 |
| Clopidogrel Clopidogrel Bisulfate | 311 | 850 | 103 | $4,318 |
| Amlodipine Besylate Generic | 278 | 753 | 88 | $1,699 |
| Metoprolol Tartrate Generic | 276 | 738 | 86 | $1,664 |
| Furosemide Generic | 228 | 575 | 82 | $1,173 |
| Carvedilol Generic | 179 | 515 | 63 | $1,395 |
| Rosuvastatin Calcium Generic | 178 | 468 | 57 | $2,885 |
| Nitroglycerin Generic | 156 | 166 | 95 | $1,324 |
| Repatha Sureclick Evolocumab | 128 | 193 | 24 | $106K |
| Spironolactone Generic | 122 | 313 | 42 | $1,079 |
| Xarelto Rivaroxaban | 121 | 222 | 26 | $116K |
| Potassium Chloride Generic | 120 | 322 | 43 | $2,273 |
Brand drugs: 880 claims; generic drugs: 4,835 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dante J Graves $79.64 ($79.64 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbott Laboratories with $79.64.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 1 | $79.64 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.